LORABID Drug Patent Profile
✉ Email this page to a colleague
When do Lorabid patents expire, and what generic alternatives are available?
Lorabid is a drug marketed by King Pharms and is included in two NDAs.
The generic ingredient in LORABID is loracarbef. Additional details are available on the loracarbef profile page.
Summary for LORABID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 4,480 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LORABID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LORABID
US Patents and Regulatory Information for LORABID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms | LORABID | loracarbef | CAPSULE;ORAL | 050668-001 | Dec 31, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | LORABID | loracarbef | FOR SUSPENSION;ORAL | 050667-002 | Dec 31, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | LORABID | loracarbef | CAPSULE;ORAL | 050668-002 | Apr 5, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |